Europe Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Software Type (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software); Delivery Mode (On-premise, and Cloud-based); End User (Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), and Business Process Outsourcing (BPO) Firms)

Market Introduction

Pharmacovigilance (PV) plays an essential role in the healthcare system through assessment, monitoring, and finding of drug interactions and their effects in human. Pharmacovigilance helps companies to monitor any adverse drug reaction events during the trial phase and also during the post marketing period.

Thus, the globalization of pharmacovigilance are expected to create a significant demand for pharmacovigilance and drug safety software in the coming years, which is further anticipated to drive the pharmacovigilance and drug safety software market.

Key medical organizations and agencies such as the European Medicines Agency and the UK Medicines and Health Regulatory Agency have provided guidelines for the execution of clinical trials and post-marketing monitoring during the COVID-19 pandemic. While these organizations understand the difficulties involved, patient safety is the focus and still should be performed as normal. The COVID-19 pandemic has caused various regulatory agencies to dramatically revise their standards, and have stressed the value of electronic reporting to ensure patient safety. Having a dedicated safety intelligence team allows an existing communication channel with authorities and the cooperation of local teams facilitates a timely and constructive communication with local authorities to plan alternative measures before it becomes necessary.

Get more information on this report :

Market Overview and Dynamics

The pharmacovigilance and drug safety software market in Europe is expected to grow from US$ 40.5 million in 2019 to US$ 71.1 million by 2027; it is estimated to grow at a CAGR of 7.1% from 2020 to 2027. Pharmacovigilance is the processes for monitoring and evaluating adverse drug reactions and it is a key component of effective drug regulation systems, clinical practice and public health programs. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled. In the current network of pharmacovigilance centers coordinated by the Uppsala Monitoring Centre, pharmacovigilance is a critical and integral part of clinical research and these days it is growing in many countries. Today many pharmacovigilance centers are working for drug safety monitoring, however, at the turn of the millennium pharmacovigilance faces major challenges in aspect of better safety and monitoring of drugs.

The centralized reporting and storage of adverse drug reaction reports will help to monitor and prevent future adverse drug reaction from the drug. European Medicines Agency (EMA) and US Food and Drug Administration (FDA) strengthening in pharmacovigilance area by interacting on different topics related to post-marketing safety, scientific exchange. Discussions on priority such as biosimilars, medicines to treat cancer, orphan medicines, medicines for children, and blood-based products, among other topics. Thus, increasing the globalization in pharmacovigilance sector helps in drug safety software. It improves the quality and efficacy of pharmacovigilance and drug safety software and is expected to favor the growth of the market during the forecast period.

Key Market Segments

In terms of software type, the adverse event reporting software segment accounted for the largest share of the Europe pharmacovigilance and drug safety software market in 2019. In terms of delivery mode, the on-premise segment held a larger market share of the pharmacovigilance and drug safety software market in 2019. In terms of end user, the contract research organizations segment held a larger market share of the pharmacovigilance and drug safety software market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Pharmacovigilance and drug safety software market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Veeva Systems, IQVIA Inc., Ennov, AB Cube, United Biosource LLC, ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, EXTEDO, Maxapplication, and Online Business Applications, Inc.

Reasons to buy report

To understand the Europe pharmacovigilance and drug safety software market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe pharmacovigilance and drug safety software market
Efficiently plan M&A and partnership deals in Europe pharmacovigilance and drug safety software market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe pharmacovigilance and drug safety software market
Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

EUROPE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SEGMENTATION

By Software Type

Fully Integrated Software
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software

By Delivery Mode

Cloud-based
On-premise

By End User

Contract Research Organizations
Pharmaceutical and Biotech Companies
Business Process Outsourcing

By Country

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Pharmacovigilance and Drug Safety Software Market – By Software Type

1.3.2 Pharmacovigilance and Drug Safety Software Market – By Delivery Mode

1.3.3 Pharmacovigilance and Drug Safety Software Market – By End User

1.3.4 Europe Pharmacovigilance and Drug Safety Software Market – By Country

2. Europe Pharmacovigilance and Drug Safety Software Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Pharmacovigilance and Drug Safety Software Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Pharmacovigilance and Drug Safety Software Market- Europe PEST Analysis

4.3 Expert Opinion

5. Europe Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Adverse Drug Reactions (ADRs)

5.1.2 Globalization of Pharmacovigilance

5.2 Market Restraints

5.2.1 Expensive Technology

5.3 Future Trends

5.3.1 Artificial Intelligence in Pharmacovigilance

5.4 Impact Analysis

6. Pharmacovigilance and Drug Safety Software Market – Europe Analysis

6.1 Europe Pharmacovigilance and Drug Safety Software Market Revenue Forecasts and Analysis

7. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Software Type

7.1 Overview

7.2 Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

7.3 Adverse Event Reporting Software Market

7.3.1 Overview

7.3.2 Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Drug Safety Audits Software

7.4.1 Overview

7.4.2 Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Issue Tracking Software

7.5.1 Overview

7.5.2 Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Fully Integrated Software

7.6.1 Overview

7.6.2 Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Delivery Mode

8.1 Overview

8.2 Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)

8.3 On-premise

8.3.1 Overview

8.3.2 On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Cloud- Based

8.4.1 Overview

8.4.2 Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts to 2027– By End User

9.1 Overview

9.2 Pharmacovigilance (PV) and Drug Safety Software Market, By End User, 2019 & 2027 (%)

9.3 Pharmaceutical and Biotech Companies Market

9.3.1 Overview

9.3.2 Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Contract Research Organizations (CROs) Market

9.4.1 Overview

9.4.2 Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Business Process Outsourcing (BPO) Firms Market

9.5.1 Overview

9.5.2 Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10. Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1 Europe: Pharmacovigilance and Drug Safety Software Market

10.1.1 Overview

10.1.2 Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.1.3 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.1 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.2 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.3.3 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.3.4 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User(US$ Mn)

10.1.4 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)

10.1.4.1 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.2 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.4.3 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.4.4 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.5 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.1 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.2 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.5.3 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.5.4 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.6 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Software Type (US$ Mn)

10.1.6.3 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)

10.1.6.4 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.7 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)

10.1.7.1 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)

10.1.7.2 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.7.3 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)

10.1.7.4 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.8 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.8.3 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)

10.1.8.4 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Pharmacovigilance and Drug Safety Software Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

12.3 Organic Developments

12.3.1 Overview

12.3.2 Organic Developments Done by Companies

12.4 Inorganic Developments

12.4.1 Overview

12.4.2 Inorganic Growth Strategies by Companies

13. COMPANY PROFILES

13.1 Veeva Systems

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 IQVIA Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Ennov

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 AB Cube

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 United Biosource LLC

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ArisGlobal LLC

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Sparta Systems

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Oracle Corporation

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Sarjen Systems Pvt. Ltd

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 EXTEDO

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Maxapplication

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Online Business Applications, Inc.

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 2. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 3. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By End User (US$ Mn)

Table 4. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 5. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 6. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 7. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 8. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 9. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 10. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Software Type(US$ Mn)

Table 11. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 12. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By End User (US$ Mn)

Table 13. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Software Type(US$ Mn)

Table 14. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)

Table 15. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 16. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 17. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)

Table 18. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 19. Organic Developments Done by Companies

Table 20. Recent Inorganic Growth Strategies by the Companies

Table 21. Glossary of Terms, Pharmacovigilance and Drug Safety Software Market

LIST OF FIGURES

Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation

Figure 2. Europe Pharmacovigilance and Drug Safety Software Market Overview

Figure 3. Adverse Event Reporting Software Segment Held Largest Share of Software Type in Pharmacovigilance and Drug Safety Software Market

Figure 4. Contract Research Organizations Segment Held Largest Share of End User in Pharmacovigilance and Drug Safety Software Market

Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Pharmacovigilance and Drug Safety Software Market - Europe PEST Analysis

Figure 7. Pharmacovigilance and Drug Safety Software Market Impact Analysis of Driver and Restraints

Figure 8. Europe Pharmacovigilance and Drug Safety Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

Figure 10. Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)

Figure 15. On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. Pharmacovigilance (PV) and Drug Safety Software Market, by End User, 2019 & 2027 (%)

Figure 18. Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Europe Pharmacovigilance and Drug Safety Software Market Revenue Overview, By Country, 2019(US$ Mn)

Figure 22. Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 23. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. Impact of COVID-19 Pandemic in European Country Markets

Figure 30. Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe pharmacovigilance and drug safety software market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe pharmacovigilance and drug safety software market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the pharmacovigilance and drug safety software market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample